Venus Medtech (Hangzhou), Inc. Class H (HK:2500) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Venus Medtech (Hangzhou) Inc. is set to hold its 2024 Second Class Meeting for holders of unlisted foreign shares on December 5, 2024, in Hangzhou, China. The meeting aims to discuss and approve proposed amendments to the company’s articles of association and Rule 2.07A. Shareholders are encouraged to attend and vote on these significant resolutions.
For further insights into HK:2500 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money